Literature DB >> 11357140

Cancer genetics.

B A Ponder1.   

Abstract

Cancer genetics has for many years focused on mutational events that have their primary effect within the cancer cell. Recently that focus has widened, with evidence of the importance of epigenetic events and of cellular interactions in cancer development. The role of common genetic variation in determining the range of individual susceptibility within the population is increasingly recognized, and will be addressed using information from the Human Genome Project. These new research directions will highlight determinants of cancer that lie outside the cancer cell, suggest new targets for intervention, and inform the design of strategies for prevention in groups at increased risk.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11357140     DOI: 10.1038/35077207

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  125 in total

1.  Aberrant methylation of the 3q25 tumor suppressor gene PTX3 in human esophageal squamous cell carcinoma.

Authors:  Jun-Xiong Wang; Yuan-Long He; Sheng-Tao Zhu; Shuo Yang; Shu-Tian Zhang
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

2.  Genetic variation in the promoter of DNMT3B is associated with the risk of colorectal cancer.

Authors:  Qian Bao; Bangshun He; Yuqin Pan; Zhipeng Tang; Ying Zhang; Lili Qu; Yongfei Xu; Chan Zhu; Fuliang Tian; Shukui Wang
Journal:  Int J Colorectal Dis       Date:  2011-04-26       Impact factor: 2.571

3.  The future of association studies of common cancers.

Authors:  Richard S Houlston; Julian Peto
Journal:  Hum Genet       Date:  2003-02-06       Impact factor: 4.132

4.  Associations of polymorphisms of folate cycle enzymes and risk of breast cancer in a Brazilian population are age dependent.

Authors:  Rita de Cássia Carvalho Barbosa; Débora Costa Menezes; Thiago Fernando Vasconcelos Freire; Diogo Campos Sales; Victor Hugo Medeiros Alencar; Silvia Helena Barem Rabenhorst
Journal:  Mol Biol Rep       Date:  2011-12-02       Impact factor: 2.316

5.  Klotho is silenced through promoter hypermethylation in gastric cancer.

Authors:  Liangjing Wang; Xian Wang; Xiaojia Wang; Pan Jie; Haiqi Lu; Shengjie Zhang; Xiaoying Lin; Emily Ky Lam; Yan Cui; Jun Yu; Hongchuan Jin
Journal:  Am J Cancer Res       Date:  2010-11-10       Impact factor: 6.166

6.  Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.

Authors:  Yuanlong He; Yongjun Wang; Peng Li; Shengtao Zhu; Junxiong Wang; Shutian Zhang
Journal:  Dig Dis Sci       Date:  2010-08-20       Impact factor: 3.199

7.  Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: correlation with tumour growth.

Authors:  Annette Lebeau; Claudia Müller-Aufdemkamp; Clarissa Allmacher; Ulrich Sauer; Andreas Nerlich; Ralf Lichtinghagen; Udo Löhrs
Journal:  J Mol Histol       Date:  2004-06       Impact factor: 2.611

8.  Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation.

Authors:  Tsuyoshi Akagi; Ken Sasai; Hidesaburo Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

9.  Predicting breast cancer risk: implications of a "weak" family history.

Authors:  Elaine Anderson; Jonathan Berg; Roger Black; Nicola Bradshaw; Joyce Campbell; Roseanne Cetnarskyj; Sarah Drummond; Rosemarie Davidson; Jacqueline Dunlop; Alison Fordyce; Barbara Gibbons; David Goudie; Helen Gregory; Kirstie Hanning; Susan Holloway; Mark Longmuir; Lorna McLeish; Vicky Murday; Zosia Miedzybrodska; Donna Nicholson; Pauline Pearson; Mary Porteous; Marta Reis; Sheila Slater; Karen Smith; Elizabeth Smyth; Lesley Snadden; Michael Steel; Diane Stirling; Cathy Watt; Catriona Whyte; Dorothy Young
Journal:  Fam Cancer       Date:  2008-06-17       Impact factor: 2.375

10.  Overview of genes, diet and cancer.

Authors:  J C Mathers
Journal:  Genes Nutr       Date:  2007-10       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.